5'-palmitoyl cytarabine has been researched along with Anorexia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, K; Ohno, R | 1 |
| Hattori, K; Hirano, M; Hoshino, A; Ito, M; Kimura, K; Maekawa, T; Miura, Y; Nakamura, T; Ohno, R; Ota, K | 1 |
2 other study(ies) available for 5'-palmitoyl cytarabine and Anorexia
| Article | Year |
|---|---|
[Treatment of myelodysplastic syndromes (MDS) with oral administration of N4-palmitoyl-1-beta-D-arabinofuranosyl cytosine (PLAC)].
Topics: Administration, Oral; Adult; Aged; Anorexia; Antineoplastic Agents; Cytarabine; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Nausea | 1988 |
Phase I clinical and pharmacokinetic study of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Bone Marrow; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukocyte Count; Male; Middle Aged; Nausea; Neoplasms | 1987 |